Custom Tailoring Therapy for Breast Cancer Using ERBB-2

Abstract

In order to examine whether erbB-2 protein over-expression influence the survival and tamixifen response in ER positive node negative breast cancer, 937 patients were examined from NSABP trial B-14. No such effect was found. ERBB-2, Breast cancer, Tamoxifen, Estrogen receptor, Survival, Therapy.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jan 14, 1994
Accession Number
ADA277614

Entities

People

  • Soonmyoung Paik

Organizations

  • Georgetown University

Tags

DTIC Thesaurus Topics

  • Alkenes
  • Biological Staining And Labeling
  • Biomedical Research
  • Breast Cancer
  • Chemistry
  • Clinical Trials
  • Data Science
  • Deoxyribonucleic Acids
  • Diseases And Disorders
  • Estrogens
  • Information Science
  • Laboratory Animals
  • Materials
  • Multivariate Analysis
  • Neoplasms
  • Recombinant Dna
  • Statistical Analysis

Readers

  • Molecular Biology and Genetics
  • Oncology
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.